Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. News Desk 2018 Message Board

Viratech to Hold Annual Shareholder Meeting on Mar

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 617763
(Total Views: 154)
Posted On: 03/17/2017 7:00:03 AM
Avatar
Posted By: News Desk 2018
Viratech to Hold Annual Shareholder Meeting on March 31, 2017

RENO NV--(Marketwired - Mar 17, 2017) - Viratech Corp. (the "Company") ( OTC PINK : VIRA ) a mobile & social networking technology company, focused on creating Social Network Application Platforms ( SNAPs ), specifically, social network driven wikis, harnessing social collaboration in a way to give the user a more in depth perspective of a researched subject or action. Announced today that Viratech, Corp. will be holding its Annual Shareholders' Meeting to be held on Friday, March 31, 2017 at 1:00 pm (PST) at 429 Plumb Lane, Reno Nevada 89509

  MATTERS ON THE AGENDA OF THE ANNUAL SHAREHOLDERS' MEETING

1. To ratify the acquisition of the Newswire.net in the purchase and sale agreement with Cancer.im. 2. To implement the Revenue Recognition policy under FASB 65 and SAB 109 in accordance to best practices. 3. To mandatorily convert all classes of issued and outstanding preferred stock. 4. To adopt better practice standards for corporate governance. 5. To engage a PCAOB auditing firm to complete a filing and registration with the SEC. 6. Evaluate Board of Directors and other key management positions to guide the Company in sales and marketing, of our new completed product offering. 7. Engage an investor relations firm to handle the communications function of the Company to its shareholders and the public markets. 8. To adopt and to ratify the creation of the following operating divisions: a. Sales Division; b. Licensing Division; c. Advertising Division; d. Build Operate Maintain Division.

About Viratech, Corp. Viratech is a mobile & social networking Technology Company, focused on creating and licensing, Social Network Application Platforms ( SNAP s), in the medical oriented vertical space. Our first network we have successfully created with our core IP offering resides at www.cancer.im/1/ and its complimenting Apple iOS Application residing at https://itunes.apple.com/us/app/cancer.im/id1195005856?mt=8 . The engine and power behind the mobile application and social networking sites is our REST API, which is available to the development community, for more information please our API documentation HERE .

Forward-Looking Statements Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward-looking statements in this press release include statements regarding our belief about the market applications. The following important factors, among others, have affected and, in the future could affect, the our actual results: the effect of new branding and marketing initiatives, the integration of new leadership, the introduction and acceptance of new products, the levels and particular directions of research and product development by our customers, the impact of the growing number of producers of biotechnology research and diagnostics products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and results of our research and product development efforts and those of companies in which we have invested or with which we have formed strategic relationships. For additional information concerning such factors, see the section titled "Risk Factors" in our annual report and quarterly reports. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.

Fred Schiemann CEO/Director Viratech Corp. Email: fschiemann@yahoo.com (775) 238-6672 Chris Ryan CEO Cancer.im, Inc. Email: chris@cancer.im (619) 354-0122 www.linkedin.com/in/cancer/



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us